These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 3054093)

  • 1. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Mertens JC; Jüngel A; Brentano F; Maciejewska-Rodriguez H; Huber LC; Hemmatazad H; Wüest T; Knuth A; Gay RE; Michel BA; Gay S; Renner C; Bauer S
    Arthritis Rheum; 2010 May; 62(5):1224-35. PubMed ID: 20155839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.
    Fiehn C; Neumann E; Wunder A; Krienke S; Gay S; Müller-Ladner U
    Ann Rheum Dis; 2004 Jul; 63(7):884-6. PubMed ID: 15194591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
    Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
    J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological studies on synovium-cartilage interactions in organ culture.
    Crossley MJ; Hunneyball IM
    Eur J Rheumatol Inflamm; 1982; 5(1):15-29. PubMed ID: 7044793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
    Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
    Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rheumatoid arthritic cartilage and its neutral proteoglycan-degrading proteases. The effects of antirheumatic drugs.
    Martel-Pelletier J; Cloutier JM; Howell DS; Pelletier JP
    Arthritis Rheum; 1985 Apr; 28(4):405-12. PubMed ID: 3921034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
    Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
    Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
    J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
    Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
    Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases.
    Abeles AM; Pillinger MH
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):20-4. PubMed ID: 17121485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.
    Hummel KM; Petrow PK; Franz JK; Müller-Ladner U; Aicher WK; Gay RE; Brömme D; Gay S
    J Rheumatol; 1998 Oct; 25(10):1887-94. PubMed ID: 9779840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
    Cutolo M; Bisso A; Sulli A; Felli L; Briata M; Pizzorni C; Villaggio B
    J Rheumatol; 2000 Nov; 27(11):2551-7. PubMed ID: 11093433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.